Skip to content

Raltegravir continues to perform well at four years

Dolutegravir is potent but twice-daily works better for integrase-resistant

Help when you're troubled: getting the right psychological support

Barriers to care: immigration removal centres and HIV

Growing pain

UK: Life expectancy on HIV treatment improving, shows importance of prompt diagnosis and treatment

Overweight patients have best gains in CD4 cell count twelve months after starting HIV therapy

Detectable viral load in patients taking HIV therapy associated with poor control of other chronic health problems

Waist circumference and triglycerides: simple measures of increased cardiovascular risk for patients with HIV